26noIntroduction: Available data indicate that a large minority of patients with COVID-19 develop ARDS, and pulmonary fibrosis is a recognized sequela of ARDS. However, the long-term pulmo- nary consequences of COVID-19 remain speculative. Objects: The aim of this study is to evaluate risk factors, preva- lence and characteristics of POST-COVID-19 interstitial lung changes, with the unique opportunity to evaluate radiologic and pathologic correlations using HRCT and transbronchial lung cryobiopsy specimens. Methods: Here we present the preliminary data on HRCT fea- tures of POST-COVID-19 ILD. Data were collected at the time of the first interim analysis (28/11/2020) of the PCOILS trial: a pro- spective, multicenter national study involvin...
Rationale The impact of COVID-19 on patients with Interstitial Lung Disease (ILD) has not been estab...
Background: We investigated whether COVID-19 leads to persistent impaired pulmonary function, fibrot...
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (...
Rationale: Shared symptoms and genetic architecture between coronavirus disease (COVID-19) and lung ...
INTRODUCTION The COVID-19 pandemic has led to over 100 million cases worldwide. The UK has had ov...
INTRODUCTION: The COVID-19 pandemic has led to over 100 million cases worldwide. The UK has had over...
RATIONALE: Shared symptoms and genetic architecture between COVID-19 and lung fibrosis suggests SARS...
RATIONALE: Shared symptoms and genetic architecture between COVID-19 and lung fibrosis suggests SARS...
Rationale: shared symptoms and genetic architecture between COVID-19 and lung fibrosis suggests SARS...
It has been recently hypothesized that infection by severe acute respiratory syndrome coronavirus 2 ...
Immunomodulation and immunity from vaccination and natural infection have reduced mortality from cor...
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (...
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (...
Background: Our aim is to evaluate the possible persistence of lung parenchyma alterations, in patie...
Since the initial identification of the novel coronavirus SARS-CoV-2 in December 2019, the COVID-19 ...
Rationale The impact of COVID-19 on patients with Interstitial Lung Disease (ILD) has not been estab...
Background: We investigated whether COVID-19 leads to persistent impaired pulmonary function, fibrot...
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (...
Rationale: Shared symptoms and genetic architecture between coronavirus disease (COVID-19) and lung ...
INTRODUCTION The COVID-19 pandemic has led to over 100 million cases worldwide. The UK has had ov...
INTRODUCTION: The COVID-19 pandemic has led to over 100 million cases worldwide. The UK has had over...
RATIONALE: Shared symptoms and genetic architecture between COVID-19 and lung fibrosis suggests SARS...
RATIONALE: Shared symptoms and genetic architecture between COVID-19 and lung fibrosis suggests SARS...
Rationale: shared symptoms and genetic architecture between COVID-19 and lung fibrosis suggests SARS...
It has been recently hypothesized that infection by severe acute respiratory syndrome coronavirus 2 ...
Immunomodulation and immunity from vaccination and natural infection have reduced mortality from cor...
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (...
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (...
Background: Our aim is to evaluate the possible persistence of lung parenchyma alterations, in patie...
Since the initial identification of the novel coronavirus SARS-CoV-2 in December 2019, the COVID-19 ...
Rationale The impact of COVID-19 on patients with Interstitial Lung Disease (ILD) has not been estab...
Background: We investigated whether COVID-19 leads to persistent impaired pulmonary function, fibrot...
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (...